Date: 18/02/2019

On Monday 18/02/2019 the SDC completed the process of decreasing the share capital of (8,619,000) JOD/share of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company with a nearly 87 percent of the company’s capital. The share capital decrease was performed through redeeming the company’s accumulated losses as of 31/12/2017.

Thereby, the SDC record of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company indicates the decrease of its capital from (9,869,583) JOD/share to a registered capital of (1,250,583) JOD/share as a result of the mentioned share capital decrease.

The above mentioned procedure is conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 31/07/2018 which was granted the approval of the Ministry of Industry, Trade, and Supply on 31/01/2019.